| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.098 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |